切换至 "中华医学电子期刊资源库"

中华介入放射学电子杂志 ›› 2014, Vol. 02 ›› Issue (01) : 31 -34. doi: 10.3877/cma j.issn.2095-5782.2014.01.009

血管介入

切割球囊在内脏血管支架内再狭窄治疗中的临床应用
张克伟1, 翟水亭1,(), 李天晓1, 史帅涛1, 王国权1   
  1. 1.450003 河南省人民医院郑州大学附属人民医院介入与血管外科
  • 收稿日期:2013-07-13 出版日期:2014-03-01
  • 通信作者: 翟水亭

Application of peripheral cutting balloon angioplasty for visceral vessel in-stent restenosis

Kewei Zhang1, Shuiting Zhai1,(), Tianxiao Li1, Shuaitao Shi1, Guoquan Wang1   

  1. 1.Department of Interventional Radiology,Henan Province Hospital,Henan,Zhengzhou 450000,China
  • Received:2013-07-13 Published:2014-03-01
  • Corresponding author: Shuiting Zhai
引用本文:

张克伟, 翟水亭, 李天晓, 史帅涛, 王国权. 切割球囊在内脏血管支架内再狭窄治疗中的临床应用[J/OL]. 中华介入放射学电子杂志, 2014, 02(01): 31-34.

Kewei Zhang, Shuiting Zhai, Tianxiao Li, Shuaitao Shi, Guoquan Wang. Application of peripheral cutting balloon angioplasty for visceral vessel in-stent restenosis[J/OL]. Chinese Journal of Interventional Radiology(Electronic Edition), 2014, 02(01): 31-34.

目的

观察切割球囊治疗内脏血管支架内再狭窄的通畅率, 评价其临床效果。

方法

回顾性分析应用切割球囊治疗的16例患者资料, 包括12例肾动脉支架内狭窄、 2例肠系膜上动脉支架内狭窄、 2例肝内门-腔静脉分流道支架内狭窄。 根据血管直径或支架大小选择相应直径的切割球囊,行球囊扩张成形术, 术后规律随访, 评价其治疗效果。

结果

16 例患者治疗均获成功, 未出现明显并发症。狭窄处血流恢复通畅, 临床症状缓解。随访9~92个月, 平均(37±9)个月, 发生再狭窄3例。

结论

切割球囊治疗内脏血管支架术后再狭窄是安全、 可靠的, 早、 中期疗效良好, 远期效果有待进一步随访。

Objective To investigate the patency and clinical outcome of peripheral cutting balloon(PCB)in treatment of visceral vessel restenosis.

Methods

Sixteen visceral vessel in-stent restenosis,in which 12 renal artery restenosis,2 superior mesenteric artery(SMA)restenosis,2 vessel restenosis after transjugular intrahepatic portosystemic shunt(TIPS),underwent angioplasty by PCB.Clinical data were collected.

Results

All procedure were carried out successfully on 16 patients,and no serous complications occurred.The symptoms die not recur in all patients after the procedure.During a mean follow-up of(37±21)months(ranging 9 to 92 months),3 vessel restenosis were found.

Conclusions

CBA is safe and effective for treatment of vessel in-stent restenosis.The early and midterm results are encouraging,but long term results require further follow-up and observation.

1
Davies MG, Saad WA, Bismuth JX, et al. Outcomes of endoluminal reintervention for restenosis after percutaneous renal angioplasty and stenting[J].J Vasc Surg,2009,49(4):946-952.
2
Mehran R, Dangas G, Abizaid A, et al. Angiographic patterns of in-stent restenosis: classification and implications for long term outcome[J].Circulation,1999,100(18):1872-1878.
3
Barath P,Fishbein MC,Vari S,et al.Cutting balloon:A novel approach to percutaneous angioplasty[J].Am J Cardiol,1991,68(11):1249-1252.
4
Tanaka R,Higashi M,Naito H.Angioplasty for non-arteriosclerotic renal artery stenosis: the efficacy of cutting balloon angioplasty versus conventional angioplasty[J].Cardiovasc Intervent Radiol,2007,30(4):601-606.
5
陈少伯,李玉明,JANGYS,等.切割球囊处理下肢动脉支架术后再狭窄的临床应用[J].中华老年心脑血管病杂志,2006,8(3):165-167.
6
Davies MG, Anaya-Ayala JE. Endovascular techniques in limb salvage:cutting,cryo, brachy,and drug-eluting balloons[J].Methodist Debakey Cardiovasc J,2013,9(2):69-72.
7
Davies MG,Saad WE,Bismuth J,et al.Impact of metabolic syndrome on the outcomes of percutaneous renal angioplasty and stenting[J]. J Vasc Surg,2010,51(4):926-932.
8
Huang Y, Salu K, Wang L, et al. Use of a tacrolimus-eluting stent to inhibit neointimal hyperplasia in a porcine cornary model[J]. J Invasive Cardiol,2005,17(3):142-148.
9
Sprague EA. In vivo cardiovascular assays for drug discovery:evolution of the drug-eluting stent[J]. Curr Opin Investing Drugs,2007,8(3):219-225.
10
Wiesinger B,Beregi JP,Oliva VL,et al.PTFE-covered self-expanding nitinol stents for the treatment of severe iliac and femoral artery stenoses and occlusions:final results from a prospective study[J]. J Endovase Ther,2005,12(2):240-246.
11
Jefferies JL,Dougherty K,Krajcer Z.First use of cryoplasty to treat instent renal artery restenosis[J].Tex Heart Inst J,2008,35(3):352-355.
12
Cejna M.Cutting balloon:review on principles and background of use in peripheral arteries[J].Cardiovasc Intervent Radiol,2005,28(4):400-408.
13
Patel PM,Eisenberg J,Islam MA,et al.Percutaneous revascularization of persistent renal artery in-stent restenosis[J]. Vasc Med, 2009,14(3):259-264.
14
Tsetis D,Morgan R, Belli AM. Cutting balloons for the treatment of vascular stenoses[J].Eur Radiol, 2006,16(8):1675-1683.
15
Philipper F, Dibie A, Larrazet F, et al, Drug eluting stents: from evidence based medicine to clinical practice[French][J].Ann Cardiol Angiol,2005,54(4):201-211.
16
Mauri L,Hsieh WH,Massaro JM,et al.Stent thrombosis in randomized clinical trials of drug-eluting stents[J]. N Engl J Med, 2007, 356(10):1020-1029.
17
Zeller T,Macharzina R,Tepe G.The potential role of DES in peripheral in-stent restenosis[J].J Cardiovasc Surg(Torino),2010,51(4):561-565.
18
Stone PA,Campbell JE,Aburahma AF,et al.Ten-year experience with renal artery in-stent stenosis[J].J Vasc Surg,2011,53(4):1026-1031.
19
Zeller T, Sixt S, Rastan A, et al. Treatment of reoccurring instent restenosis following reintervention after stent-supported renal artery angioplasty[J].Catheter Cardiovasc Interv,2007,70(2):296-300.
20
Zeller T, Rastan A, Schwarzwälder U, et al. Endovascular therapy of chronic mesenteric ischaemia[J].EuroIntervention,2007,2(4):444-451.
21
Cura M, Cura A, Suri R,et al. Causes of TIPS dysfunction[J].Am J Roentgenol,2008,191(6):1751-1757.
22
Jirkovsky V, Fejfa T, Safka V, et al. Influence of the secondary deployment of expanded polytetrafluoroethylene-covered stent grafts on maintenance of transjugular intrahepatic portosystemic shunt patency[J].J Vasc Interv Radiol, 2011,22(1):55-60.
23
Shipovskil VN, Tasitsiashvili MSh, Saakian AM, et al. Repeat endovascular interventions after transjugular intrahepatic portosystemic shunt(tips)procedures[J].Angiol Sosud Khir,2010,16(2):37-40.
[1] 孙艺玮, 陈炜, 秦巍, 杜景辰, 孟昕, 周永军. 血管腔内介入治疗糖尿病足合并下肢动脉硬化闭塞症患者术后再狭窄与血清炎症因子的相关性[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(01): 34-40.
[2] 麦子结, 曾学晴, 张乾升, 刘永达. 输尿管软镜术后严重出血治疗的初步探索[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 366-371.
[3] 潘兴赫, 董翔, 杨海洋, 张雪斌, 甘卫东. 超选择性前列腺动脉栓塞治疗伴急性尿潴留的高危高龄前列腺增生[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(03): 237-242.
[4] 朱良振, 于永刚, 陈杲, 廖松柏. 儿童高级别闭合性肾损伤肾动脉栓塞与手术探查的疗效比较[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 461-465.
[5] 杨金朔, 吴桥伟, 王春雷, 史怀璋. 脑血管内支架成形术后再狭窄的研究进展[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(03): 174-179.
[6] 赵峰, 邓默. 纤维蛋白原水平、踝肱指数与外周血管支架治疗下肢动脉硬化闭塞症后再狭窄的关系[J/OL]. 中华临床医师杂志(电子版), 2024, 18(02): 144-151.
[7] 崔伟, 叶苏意, 邓屹, 陈晓明, 张靖, 李静, 许荣德. 载药微球支气管动脉化疗栓塞术治疗难治性非小细胞肺癌的临床疗效及安全性[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 311-316.
[8] 郭亚潘, 孙敬, 孙鹏程, 张鑫, 朱碧云, 李智, 倪才方. 超选择栓塞治疗急性肾出血及CT血管成像在显示责任血管中的作用[J/OL]. 中华介入放射学电子杂志, 2024, 12(02): 155-160.
[9] 徐啸阳, 张帅, 仲斌演, 沈健, 朱晓黎. 血管腔内介入治疗肾动脉瘤的临床疗效分析[J/OL]. 中华介入放射学电子杂志, 2024, 12(02): 137-143.
[10] 庞宁东, 蒋贻洲, 姜华, 牛传强, 李海波, 刘浪, 刘珍银, 张靖. 经皮腔内血管成形术治疗儿童肾动脉狭窄的疗效及相关因素分析[J/OL]. 中华介入放射学电子杂志, 2024, 12(01): 22-26.
[11] 杨伟洪, 向先俊, 郭宗锦, 王亮, 周汝明, 魏民新, 王赞鑫. 主动脉夹层累及腹腔分支二期腔内治疗的中期研究[J/OL]. 中华介入放射学电子杂志, 2023, 11(03): 236-240.
[12] 张超, 罗涛, 李昂, 朱林忠, 刘东斌, 林栋栋, 李非, 敖国昆. 医源性胆道大出血的介入治疗体会[J/OL]. 中华介入放射学电子杂志, 2023, 11(03): 212-217.
[13] 王亚芳, 荣素然, 石向欣, 杨晓欧, 许金金, 王敬祥. 切割球囊对老年轻中度冠状动脉钙化病变患者远期预后的影响[J/OL]. 中华老年病研究电子杂志, 2024, 11(03): 19-23.
[14] 赵昌云, 汪月奔, 虞意华, 严静, 龚仕金. 超声肾脏血流动力学监测对老年患者右心功能衰竭的诊断价值[J/OL]. 中华老年病研究电子杂志, 2023, 10(03): 22-25.
[15] 牟磊, 徐东成, 韩鑫, 徐长江, 韩坤锜, 薛叶潇, 牟媛, 秦文玲, 刘相静, 陈哲, 高楠. 五虫通络胶囊防治椎动脉开口支架术后再狭窄发生的效果[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 467-472.
阅读次数
全文


摘要